-
Pfizer forecasts in line 2025 profit as it seeks turnaround
22 Dec 2024 05:20 GMT
… Starboard in October saying that Pfizer’s management has over-spent … we see several assets in Pfizer’s pipeline (particularly in oncology … in a research note.
Pfizer forecast 2025 revenue in the … Biden’s Inflation Reduction Act.
Pfizer said the addition of new …
-
USFDA nod to Pfizer Braftovi Combination Regimen for BRAF V600E-Mutant Metastatic Colorectal Cancer
21 Dec 2024 11:28 GMT
… .
“For more than a decade, Pfizer has been a pioneer in … Oncology Officer, Executive Vice President, Pfizer. “This milestone adds to our …
-
Pfizer Vaccine Reduces Risk of Long COVID in Pediatric Patients
20 Dec 2024 22:58 GMT
Pfizer’s BNT162b2 COVID-19 vaccine …
-
Pfizer cost cutting leads to Tampa layoffs
20 Dec 2024 22:38 GMT
-
Accelerated approval brings Pfizer's BRAF inhibitor to first-line patients
20 Dec 2024 20:32 GMT
-
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
20 Dec 2024 19:17 GMT
… information shortly.
About Pfizer Oncology
At Pfizer Oncology, we are … and longer lives.
About Pfizer: Breakthroughs That Change Patients’ … us on X at @Pfizer and @Pfizer_News, LinkedIn, YouTube … at Facebook.com/Pfizer.
Disclosure Notice
The information …
-
Easton residents denounce plans for massive warehouse at old Pfizer plant near residential area
20 Dec 2024 14:31 GMT
… proposed warehouse at the former Pfizer Pigments manufacturing facility off Route … the site of the former Pfizer pigments plant, until it … in 2020 at the old Pfizer plant Tuesday in Wilson. … the property was known as Pfizer Corp. and later Harcross Pigments …
-
Neuropathic Pain Market Set to Witness Significant Growth by 2024-2031 | Pfizer, Inc., Johnson & Johnson Services
20 Dec 2024 11:39 GMT
… players analyzed in the report:
• Pfizer Inc.
• Johnson & Johnson Services …
-
Phenobarbital Market CAGR of 5% Trends and Growth Analysis By 2024 to 2031 | Sanofi, Pfizer Inc., Novartis AG, H.
20 Dec 2024 11:39 GMT
… analyzed in the report:
• Sanofi
• Pfizer Inc.
• Novartis AG
• H. Lundbeck …
-
Playing catch-up with Pfizer and Roche, China-made ALK drug clears FDA in lung cancer
19 Dec 2024 20:01 GMT
… , Ensacove is clearly better than Pfizer’s first-generation Xalkori. But … Alecensa, Takeda’s Alunbrig and Pfizer’s third-generation med Lorbrena … .28 billion) in sales, while Pfizer’s Lorbrena commanded $538 million …